OBJECTIVE:To observe the clinical efficacy and safety of Kangfuxin solution combined with rhEGF solution for external use in the treatment of vitamin B12 deficiency atrophic glossitis. METHODS:Totally 94 patients with vitamin B12 deficien-cy atrophic glossitis in Xinjiang Production and Construction Corps Hospital during Jul. 2012-Jun. 2015 were divided into observa-tion group and control group according to random number table,with 47 cases in each group. Both groups received etiological treat-ment of vitamin B12 supplement. Control group was additionally given rhEGF solution for external use on tongue surface,qid. Based on control group,observation group was additionally given Kangfuxin solution and applied medical gauze saturated with liq-uid medicine to the affected area,more than 30 min each time,tid. Treatment course of 2 groups lasted for 4 week,a referral of the week. Clinical efficacies were compared between 2 groups as well as average pain indexes and lesion areas of tongue before and after treatment,and the occurrence of ADR. RESULTS:Cure rate(76.6% vs. 57.4%)and total response rate(97.9% vs. 83.0%) of observation group were significantly higher than those of control group,with statistical significance (P0.05). 1-4 weeks after treatment,average pain indexes and lesion areas of tongue in 2 groups were significantly decreased,with statistical sig-nificance compared to before treatment (P0.05);治疗后1~4周,两组患者的平均疼痛指数明显降低,舌部病损面积均明显减小,与治疗前比较差异均有统计学意义(P<0.05);且观察组患者的平均疼痛指数明显低于对照组(治疗后3、4周),舌部病损面积明显小于对照组(治疗后2~4周),差异均有统计学意义(P<0.05).两组患者均未见明显不良反应发生.结论:康复新液联合rhEGF外用溶液治疗维生素B12缺乏型萎缩性舌炎能明显改善患者舌部病损情况,并具有较好的镇痛效应和安全性.
展开▼
